Selank is a synthetic tuftsin analog developed in Russia for anxiolytic and nootropic effects; off-label use centers on anxiety relief and cognitive focus, though the community corpus stands at just seven captured reports, all of medium confidence. Clinician guidance points to daily subcutaneous injections of 250–750 mcg, typically cycled for one to three weeks; one source mentions an oral formulation, but subcutaneous delivery remains the prevalent route. It holds no FDA-approved indication, so all human use is off-label or compounded.

Research Evidence
Evidence shape
Selank sits at the animal-only tier; the sole mapped indication is preclinical mechanistic research, and the record contains zero registered human trials of any kind. Because no trials have been completed, there are no blinded results, no outcomes to parse, and no human evidence to weigh for any mapped indication. That total absence of human testing is the central signal: the compound remains confined to exploratory animal work and has not advanced into clinical investigation.
Anecdotal efficacy
Side effects
Clinical research side effects
Clinical safety table not projected yet.
Anecdotal side effects
Price
price offers can be sorted by column
Dosing & Protocol
How Selank is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
No structured protocol details captured for this tier yet.
Clinician protocols dose 250 µg–750 µg daily subQ (4 sources).
No structured protocol details captured for this tier yet.
Community reports show Selank is anecdotally used for anxiety reduction (75% positive reports) and cognitive enhancement (100% positive reports). Specific dosage details were not consistently available in the community reports analyzed.
Peptide Deep Dive
Peptide Deep Dive is not projected for this peptide yet.
Peptide feedback
0 forum repliesLive community discussion for Selank, shown here in the site layout and continued on the TVR forum.
No peptide feedback yet
Start the peptide feedback thread on the TVR forum.